✦ LIBER ✦

A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

✍ Scribed by Gatzemeier, U; Faderl, B; Macha, H; Kaukel, E; Deppermann, K.-M; Bonnet, R; Hessler, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First — line chemotherapy in SCLC: a pha

✍ M. Reck; J. Von Pawel; H. Macha; E. Kaukel; K. Deppermann; B. Bonnet; S. Hessler 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Chemotherapy of patients with extensive

✍ Gatzemeier, U.; Neuhauss, R.; Pawel, J.v.; Laumen, R.; Hossfeld, D.K. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Dose intensity phase III trial with ifos

✍ Hanauske, A-R; Korfel, A; Perker, M; Heinrich, B; Schwab, G; Graf, M; Depenbrock 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Cisplatin/etoposide versus carboplatin/e

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 268 KB

A phase II trial of carboplatin (C), ifo

✍ Casal, J.; Garcia, J.; Garrido, P.; Movand, A.; Crespo, C.; Diz, P. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A phase II trial of ifosfamide (I), etop

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB